Macrogenics (MGNX) Tops Q2 EPS by 19c

Macrogenics (NASDAQ: MGNX) reported Q2 EPS of ($1.03), $0.19 better than the analyst estimate of ($1.22). Revenue for the quarter came in at $18.8 million versus the consensus estimate of $4.21 million.

For earnings history and earnings-related data on Macrogenics (MGNX) click here.

You May Also Be Interested In

• Lockheed Martin (LMT) Tops Q1 EPS by 53c, Beats on Revenue; Offers FY24 Guidance
• Dime Community Bancshares (DCOM) Tops Q1 EPS by 1c
• Lockheed Martin (LMT) Tops Q1 EPS by 59c, Beats on Revenue; Offers FY24 Guidance